Role of Plastic Surgery in the Treatment of Titanium Mesh Exposure Following Cranioplasty.


Journal

The Journal of craniofacial surgery
ISSN: 1536-3732
Titre abrégé: J Craniofac Surg
Pays: United States
ID NLM: 9010410

Informations de publication

Date de publication:
01 Jun 2024
Historique:
received: 17 06 2023
accepted: 12 02 2024
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: ppublish

Résumé

Titanium mesh cranioplasty is the most common strategy for the repair of skull defects. However, as the frequency of cranioplasty increases, the incidence of titanium mesh exposure following cranioplasty increases as well. This study aimed to investigate the methods and outcomes of plastic surgery in the management of titanium mesh exposure following cranioplasty. Patients with titanium mesh exposure following cranioplasty were retrospectively selected from January 2016 to August 2021. Titanium mesh exposure was corrected with reconstructive plastic surgery, including skin grafting, expander insertion, partial removal of the exposed mesh, replacement of the mesh, or flap transplantation. This study included 21 patients with titanium mesh exposure with surgical site infection and a variant of scalp deformity. The age of the patients ranged from 18 to 74 years, with the mean age being 54 years. All patients underwent reconstructive plastic surgery and exhibited complete wound healing. The follow-up period ranged from 17 to 90 months. One patient experienced titanium mesh re-exposure and subsequently underwent an additional procedure for the partial removal of the exposed mesh. No serious complications were observed postoperatively. Reconstructive plastic surgery can facilitate wound healing at the titanium mesh exposure site following cranioplasty. However, an individualized treatment strategy is required for each patient, and complications should be managed by adopting standard measures.

Sections du résumé

BACKGROUND BACKGROUND
Titanium mesh cranioplasty is the most common strategy for the repair of skull defects. However, as the frequency of cranioplasty increases, the incidence of titanium mesh exposure following cranioplasty increases as well. This study aimed to investigate the methods and outcomes of plastic surgery in the management of titanium mesh exposure following cranioplasty.
METHODS METHODS
Patients with titanium mesh exposure following cranioplasty were retrospectively selected from January 2016 to August 2021. Titanium mesh exposure was corrected with reconstructive plastic surgery, including skin grafting, expander insertion, partial removal of the exposed mesh, replacement of the mesh, or flap transplantation.
RESULTS RESULTS
This study included 21 patients with titanium mesh exposure with surgical site infection and a variant of scalp deformity. The age of the patients ranged from 18 to 74 years, with the mean age being 54 years. All patients underwent reconstructive plastic surgery and exhibited complete wound healing. The follow-up period ranged from 17 to 90 months. One patient experienced titanium mesh re-exposure and subsequently underwent an additional procedure for the partial removal of the exposed mesh. No serious complications were observed postoperatively.
CONCLUSION CONCLUSIONS
Reconstructive plastic surgery can facilitate wound healing at the titanium mesh exposure site following cranioplasty. However, an individualized treatment strategy is required for each patient, and complications should be managed by adopting standard measures.

Identifiants

pubmed: 38829144
doi: 10.1097/SCS.0000000000010145
pii: 00001665-202406000-00015
doi:

Substances chimiques

Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1080-1083

Informations de copyright

Copyright © 2024 by Mutaz B. Habal, MD.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Mukherjee S, Thakur B, Haq I, et al. Complications of titanium cranioplasty—a retrospective analysis of 174 patients. Acta Neurochir 2014;156:989–998
Thien A, King NKK, Ang BT, et al. Comparison of polyetheretherketone and titanium cranioplasty after decompressive craniectomy. World Neurosurg 2015;83:176–180
Zhang Q, Yuan Y, Li X, et al. A large multicenter retrospective research on embedded cranioplasty and covered cranioplasty. World Neurosurg 2018;112:e645–e651
Yeap MC, Tu PH, Liu ZH, et al. Long-term complications of cranioplasty using stored autologous bone graft, three-dimensional polymethyl methacrylate, or titanium mesh after decompressive craniectomy: a single-center experience after 596 procedures. World Neurosurg 2019;128:e841–e850
Kwiecien GJ, Sinclair N, Coombs DM, et al. Long-term effect of cranioplasty on overlying scalp atrophy. Plast Reconstruct Surg Global Open 2020;8:e3031; Publish Ahead of Print
Yoshioka N, Tominaga S. Titanium mesh implant exposure due to pressure gradient fluctuation. World Neurosurg 2018;119:e734–e739
Singh M, Ricci JA, Dunn IF, et al. Alloderm covering over titanium cranioplasty may minimize contour deformities in the frontal bone position. J Craniofac Surg 2016;27:1292–1294
Cordaro ER, Calabrese S, Faini GP, et al. Method to thicken the scalp in calvarian reconstruction. J Craniofacl Surg 2011;22:598–601
Kumar NG, Sudeep S, Balwan R. Cranioplasty of hemispherical defects using calcium phosphate cements along with titanium mesh: Our experience. J Maxillofac Oral Surg 2015;14:920–924
Ducic Y. Titanium mesh and hydroxyapatite cement cranioplasty: A report of 20 cases. J Oral Maxillofac Surg 2002;60:272–276
Gundeslioglu OA, İnce B. Exposed titanium mesh and dura persisting for 8 years after cranioplasty. J Craniofac Surg 2013;24:655–656
Zhang SL, Lee H, Cai EZ, et al. Dermointegration in the exposed titanium cranioplasty: a possible protective phenomenon. J Surgl Case Reports 2021;2021:rjaa551

Auteurs

Hui Wang (H)

Department of Plastic Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH